Gestational Age Window for Laser Therapy in TAPS

Disease Stage-Based Approach

The American College of Obstetricians and Gynecologists recommends fetoscopic laser surgery for Twin Anemia Polycythemia Sequence (TAPS) can be performed in the second or early third trimester, specifically when advanced-stage disease (stage II or higher) is identified before 32 weeks of gestation 1, 2, 3
For stage I TAPS, close monitoring is the preferred strategy rather than intervention before 32-34 weeks of gestation, according to the American College of Obstetricians and Gynecologists 1, 3
For stage I TAPS, delivery should be considered rather than laser therapy at or after 32-34 weeks of gestation, as recommended by the American College of Obstetricians and Gynecologists 1, 2
Patients with advanced-stage TAPS (stage II or higher) identified in the second or early third trimester are candidates for laser therapy, as stated by the Society for Maternal-Fetal Medicine 1, 2, 3
The Society for Maternal-Fetal Medicine recommends mandatory referral to a specialized fetal care center when TAPS progresses to stage II before 32 weeks of gestation 1, 2, 3

The lower limit for laser therapy is around 16 weeks when surveillance for monochorionic complications begins, according to the Society for Maternal-Fetal Medicine 1, 4
The upper limit for laser therapy is before 32 weeks of gestation, as delivery becomes the preferred management at 32-34 weeks, as recommended by the American College of Obstetricians and Gynecologists 1, 2, 3

For TAPS diagnosed before 32 weeks, the American College of Obstetricians and Gynecologists recommends determining disease stage using MCA-PSV Doppler criteria 1, 4
For stage I TAPS, the American College of Obstetricians and Gynecologists recommends implementing close monitoring with serial ultrasounds 1, 3
For stage II or higher TAPS, the Society for Maternal-Fetal Medicine recommends referring immediately to a fetal intervention center for laser therapy evaluation 1, 2, 3
The American College of Obstetricians and Gynecologists recommends considering coexisting complications that may influence timing 1, 3

The optimal management strategy for early-onset, severe TAPS remains incompletely defined, with available options including expectant management, intrauterine transfusion, or fetoscopic laser surgery, according to the American College of Obstetricians and Gynecologists 1, 2, 3
Unlike TTTS, TAPS laser therapy recommendations are based on lower-quality evidence and require individualized decision-making at specialized centers, as stated by the Society for Maternal-Fetal Medicine 1, 2

The American College of Obstetricians and Gynecologists recommends confirming chorionicity and amnionicity by first-trimester ultrasound, ideally 10-13 weeks' gestation, to establish the diagnosis of monoamnionicity 5
Ultrasound surveillance should begin at 16 weeks' gestation to monitor for twin-twin transfusion syndrome (TTTS) and twin anemia-polycythemia sequence (TAPS), with assessments including amniotic fluid volume, urine-filled fetal bladders, umbilical artery Doppler studies, and middle cerebral artery peak systolic velocity measurements 5
Surveillance should be performed at least every 2 weeks until viability is reached 5

The American College of Obstetricians and Gynecologists recommends administering one course of corticosteroids for fetal lung maturation at 24-33 6/7 weeks, particularly given the planned preterm delivery 6

If TTTS develops, refer immediately to a fetal intervention center for evaluation, and consider fetoscopic laser surgery as the standard treatment for stage II-IV TTTS presenting between 16-26 weeks 5
After successful laser treatment, delivery timing may be extended to 34-36 weeks if both twins survive, according to the American Journal of Obstetrics and Gynecology 5
If TAPS develops, consult with a specialized fetal care center when TAPS progresses to stage II before 32 weeks or when coexisting complications arise 5

The American College of Radiology recommends initiating frequent nonstress testing (NST) or biophysical profile testing after viability, typically starting around 24-28 weeks, with some protocols using daily or twice-daily NST as delivery approaches, as NST and biophysical profile surveillance in MoMo twins is as reliable as in singleton gestations for detecting fetal compromise 7
The American College of Radiology suggests beginning biweekly ultrasound surveillance at 16 weeks for twin-twin transfusion syndrome (TTTS) and twin anemia-polycythemia sequence (TAPS), including amniotic fluid volume, bladder visualization, umbilical artery Doppler, and middle cerebral artery peak systolic velocity, to inform delivery decisions 7